Skip to main content
PLOS One logoLink to PLOS One
. 2022 Oct 3;17(10):e0275331. doi: 10.1371/journal.pone.0275331

Risk perception, community myth, and practices towards COVID-19 pandemic in Southeast Ethiopia: Community based crossectional study

Ahmednur Adem Aliyi 1,*, Musa Kumbi Ketaro 1, Zinash Teferu Engida 1, Ayele Mamo Argaw 2, Abduljewad Hussen Muhammed 1, Mesud Mohammed Hassen 2, Abdushekur Mohammed Abduletif 3, Damtow Solomon Shiferaw 4, Abate Lette Wodera 1, Sintayehu Hailu Ayene 1, Jeylan Kassim Esmael 1, Edao Sinba Etu 1
Editor: Soham Bandyopadhyay5
PMCID: PMC9529088  PMID: 36190988

Abstract

Objective

The objective of this study was to assess risk perception, community myths, and preventive practice towards COVID-19 among community in Southeast Ethiopia, 2020.

Methods

Community-based cross-sectional study was conducted among 854 participants selected using a multistage sampling technique. Data were collected using a structured questionnaire adapted from previous literature. Descriptive statistics were done to summarize the variables. A generalized linear model with binary logistic specification was used to identify factors associated with risk perception and practice. Accordingly adjusted odds ratios with 95% confidence intervals were calculated and those with p-value < 0.05 were considered as significant factors associated with risk perception and practice. Cluster analysis using a linear mixed model was performed to identify factors associated with community myth and those with p-value <0.05 were reported as significant factors associated with community myth.

Results

All 854 respondents gave their answer yielding 100% response rate. Of these 547 (64.1%) were male, 611 (71.5%) were rural residents, 534 (62.5%) got information about COVID-19 from TV/radio, 591 (69.2%) of them live near health facility, 265 (30.8%) have a history of substance use and 100 (11.7%) have a history of chronic illness, and 415 (48.6%) of them have a high-risk perception, 428 (50.1%) have a wrong myth about COVID-19 and 366 (42.9%) have poor practice respectively. Residence, distances from health facility and myths were significantly associated with risk perception. Occupation, knowledge, and practice were significantly associated with community myths. Also level of education, living near health facilities, having good knowledge and wrong myth were significantly associated with the practice of utilizing COVID-19 preventive respectively.

Conclusion

The study found high-risk perception, high wrong community myth, and relatively low utilization of available practices towards COVID-19 and factors associated with them.

Introduction

COVID-19 was initially started in December 2019, and later it was stated as pandemic and has been declared as a Public Health Emergency of International Concern by the WHO [1]. Approximately, 20.0% of COVID-19 patients developed severe symptoms, which included respiratory and bleeding disorders [2]. The virus can also be transmitted through the respiratory tract of patients with signs and symptoms but can also transmit from asymptomatic individuals before the onset of clinical features [3]. Susceptibility to COVID-19 looks to be associated with sociodemographic characteristics such as low education, age, and low access to information as well as with underlining co-morbidities like diabetic mellitus, cancer, and chronic respiratory illnesses [4].

The contagious COVID-19 virus outbreaks needs a urgent response from all stakeholders and communities [5]. Increasing public awareness and working in collaboration with the communities has endless benefits in curbing this pandemic [6]. People’s risk perception of the pandemic affects the utilization of available preventive measures [7]. The true risk from the COVID-19 virus might be low, but it gets media attention and become the candidate of social media discussion, which might have effects on risk perception, which in turn may determine communities’ behavior in adopting and using these pandemic preventive measures [8]. Understanding the risk perception among people was crucial to understand ways of delivering information for communities using correct information channeling [5, 9]. Few studies conducted previously reveal conflicting findings on the level of perceived risk towards Novel Coronavirus. One survey conducted in Italy identified the effect of age on risk perception and recommend importance of delivering correct information about the disease and its prevention mechanism [10].

The others studies conducted in Iran found moderate risk perception in the community [11, 12]. Opposing to the above two, the study conducted in United States reveals a low level of risk perception [13]. Perceived risk differs across different sociodemographic characteristics including age, educational level, residence, and access to information [9, 11, 14]. The study conducted on COVID-19 risk perception in Vietnam also identified the effect of using social media on risk perception towards COVID-19 [5].

Misinformations that transmit from different media also start helping the effect of this pandemic in affecting people’s behavior towards it. This leads to the development of some popular myths like “COVID-19 doesn’t exist at all”, “it can’t affect people in the hot or cold environment” and “COVID-19 was deliberately created by the people”. These myths have good and bad consequences on health [15]. These bulk of the information which is circulating through multiple channels influences how people think about the disease and their readiness to stick to available preventive methods [5]. This mandate as channeling of basic information should be from trusted sources. Various studies identified the level of utilizing available COVID-19 pandemic preventive techniques and variability of using these methods across different sociodemographic and socioeconomic characteristics [11, 16, 17]. Hence understanding level of risk perception towards the COVID-19 pandemic, identifying myth developed in the communities following this pandemic, and their utilization of available preventive measures has crucial importance in reducing COVID- 19 transmission. Therefore this study was conducted to identify risk perception, community myth, and practice towards COVID-19 pandemic in Southeast Ethiopia.

Methods

Study setting, design, and period

A community-based crossectional study was conducted from March to June 2020 among 854 adult populations who were permanent residents of 22 Kebeles in two Zones of the Oromia region, Southeast Ethiopia.

Inclusion and exclusion criteria

Respondents with an age greater than 18 years were included. Any individual who was not a permanent resident of the study area, critically ill, with hearing impairment, and has changes in consciousness level or cognitive disorders were excluded from the interview.

Sample size determination

Single population proportion formula for sample size determination was used to calculate the required sample size by taking the proportion of participants with high-risk perception against COVID-19 50%; at 95% confidence level, 5% margin of error, 10% non-respondents, and design effect of 2. This gave the final sample size of 854 individuals.

n=z/22p(1-p)d2

After multiplying by design effects = 768. Then 10% of non -respondent rate was added and the overall sample size became 854.

Sampling procedure and data collection

A multistage sampling technique was used in which woredas and administrative towns were selected after grouping. From selected woredas and administrative towns 22 kebeles (villages) were selected by using lottery methods. Then 854 participants were randomly included from systematically selected households. Data regarding risk perception, community myth, and preventive practice against COVID-19 were collected using tools adapted from previous studies and WHO recommendations [2, 5, 13, 1824]. Data regarding sociodemographic characteristics and source of information about COVID-19 were collected by using tools adapted from EDHS and previous articles [9, 16, 19, 25]. The questionnaire was initially prepared in English and then translated into Afan Oromo. Translation back to English was done to check for consistency by languages experts. A questionnaire pretest was done before actual data collection on 5% of the sample size. The questionnaire was modified based on pre-test results.

Data were collected by trained data collectors. Two days training was given to the data collector on objectives, relevance of the study, confidentiality, respondent right, informed consent, and on actual data collection procedures. Ethical clearance from Madda Walabu University Research and publication and letter of permission from selected woredas and administrative towns were obtained. After a brief description of the objectives of the study to every study participant oral consent was obtained. Then questionnaires were administered face to face by the data collectors. This is the appropriate approach for people with no formal education. During data collection data collectors gives clarification to the questions misunderstood by respondents. Consistency and completeness of data were checked by investigators every day. After data collection, filled questionnaires were kept carefully.

Variables measurements

Risk perceptions of respondents were assessed by asking six questions adapted from previously conducted studies [11, 26, 27], Total risk perception score was computed by adding individual responses of these six questions. Then median score was used to categorize the level of risk perception. Respondents those score less than the median were categorized as having low-risk perception, and those scores equal to or above the median were categorized as having high-risk perception regarding the COVID-19 pandemic.

Myths about COVID-19 pandemic were also measured by asking six questions adapted from previous studies [21, 22, 28]. The total myth score was calculated by adding responses to these six questions. The median score was used to label individuals as with wrong myth and not with wrong myth. Accordingly, those scores less than the median were categorized as having no wrong myth, and those scores equal to or greater than the median were categorized as having wrong myth.

Regarding utilization of preventive practice towards COVID-19; respondents were asked twelve questions adapted from World Health Organization advice to the public and previous studies [2932]. The total practice scores was computed by adding responses to these questions. And median score was used to categorize practice of participants. Accordingly practice of respondents regarding utilization of COVID-19 pandemic preventive measures was categorized as having poor practice and good practice based on their median score computed from these twelve asked questions. Those with a score below the median were categorized as having poor practice and those with a score greater than or equal with median were categorized as having good practice. Refer to appendix one for the questionnaire. The data about sociodemographic variables, access to health care, and source of information were collected by adapting tools from EDHS 2016 and previous studies after some modification.

Data processing and analysis

Data were checked for completeness and entered to Epidata version 3.1 and were exported to SPSS version 25 for analysis. Data cleaning was done using frequency distribution and descriptive statistics. The scores for risk perception, community myth and practice in utilization of COVID-19 were computed from their respective individual questions responses. Sociodemographic characteristics, access to health care and source of information were summarized using frequency distribution. Average values of all outcomes were calculated and reported. The scores of risk perception, community myth, and preventive practice were compared across different sociodemographic characteristics of respondents. A generalized linear model was used to examine factors associated with risk perception and practice regarding the utilization of available COVID-19 preventive measures. Adjusted odds ratio with a 95% confidence interval was computed and those with a p-value less than 0.05 were reported as significant factors associated with risk perception and practice. Cluster analysis by using a linear mixed model was performed to identify factors associated with community myth. Variables with a p-value less than 0.05 in the linear mixed model were reported as significant factors associated with community myth.

Results

Sociodemographic characteristics of respondents

As shown in “Table 1” below 854 respondents participated in this study yielding 100% response rate. Out of the total 854 respondents, 547 (64.1%) were male and 845 (98.9%) were Oromo ethnicity, 611 (71.5%) were rural residents. Regarding occupational status, 499 (58.4%) were farmers, the roles of 660 (77.3%) were father/mother and the majority of them attends primary level of education 335 (39.2%). Concerning their marital status, 645 (75.5%) were married earning the median monthly income of 1675.27 ETB. Around two-thirds of the respondents 534 (62.5%) got information about COVID-19 from TV/radio, 591 (69.2%) of them live near health facility and 265 (30.8%) have a history of substance use mostly khat 228 (26.7%) and 100 (11.7%) of them have a history of chronic illness. Finally, more than two-thirds of the total participants 604 (70.7%) live in their own house.

Table 1. Sociodemographic characteristics of study participants.

Variables Frequency (n) Proportion (%)
Gender
Male 547 64.1
Female 307 35.9
Age in years
Mean 34.12
Standard deviation 13.29
Minimum 16
Maximum 90
Ethnicity
Oromo 845 98.9
Amhara 4 0.5
Tigre 3 0.4
Others 2 0.2
Residence
Rural 611 71.5
Urban 243 28.5
Occupation
Government workers 113 13.2
NGO employee 7 0.8
Private workers 161 18.9
Farmers 499 58.4
Others 74 8.7
Role in family
Father/Mother 660 77.3
Son 143 16.7
Daughter 51 6
Level of education
No formal education 213 24.9
Primary education (1–8) 335 39.2
Secondary education (9–12) 178 20.8
College and above (12+) 128 15
Marital status
Married 645 75.5
Single 183 21.4
Divorced 24 2.8
Others 2 0.2
Average monthly income ETB
Median 1675.27
Minimum 10
Maximum 50000
Source of information
Religious leaders 157 18.4
TV/radio 534 62.5
Social media 285 33.4
Health workers 55 6.4
Gov’t announcements 74 8.7
Another source (like telecom) 1 0.1
Distance from health facility
Near health facility 591 69.2
Long-distance > 1 hour 256 30
Don’t know 7 0.8
Substance use
No 589 69
Yes 265 31
Types of substance used
Khat 228 26.7
Cigarettes smoking 33 3.9
Alcohol drinking 28 3.3
Other substance 1 0.1
History of chronic illness
No 754 88.3
Yes 100 11.7
House ownership
No 250 29.3
Yes 604 70.7

Distribution of risk perception, community myth and preventive practices towards COVID-19 in communities, 2020 (n = 854)

Risk perception towards COVID-19 was computed from six questions. Its median score is 19 ranging from six to thirty. Those who have risk perception greater than the median score were classified as having high-risk perception. Accordingly around half of the study participants (415 (48.6%) have high-risk perceptions. Risk perception is the same across gender and residence but comparably higher among those who live near health facilities, non-governmental workers, and have a history of chronic illness.

Community myth was assessed by asking six questions. Based on this 428 (50.1%) of the study participants have the wrong myth about the COVID-19 pandemic. The median community myth was higher among females and urban residents. Concerning its distribution across occupation types, it was higher among NGO workers and the lowest among farmers. Also, the lower community myth was scored among less educated and those with a history of substance use. It was also relatively higher among those with a history of chronic illness.

The scores for practice towards utilization of COVID-19 pandemic was computed from 12 questions and the median score was used to categorize participants. Of all participants, 366 (42.9%) of them had low utilization of the stated preventive practice.

There is no gender difference in using practice to prevent COVID-19. Using these preventive practices was higher among urban residents and those near to health facilities but relatively lower among farmers, those without formal education, and substance users. See “Table 2” below.

Table 2. Distribution of risk perception, community myth, and preventive practices towards COVID-19.

Variables Frequency(n) Percent(%)
Risk perception
Minimum 6
Maximum 30
Median 19
Myth
 Not all people develop a severe condition
No 511 59.8
Yes 343 40.2
Eating/contacting wild animals could cause COVID-19
No 368 43.1
Yes 486 59.6
Traditional medicine could prevent/cure COVID-19
No 682 79.9
Yes 171 20
COVID-19 was deliberately created by people
No 796 93.2
Yes 58 6.8
Living in a hot/cold environment could prevent COVID-19
No 763 89.3
Yes 91 10.7
COVID-19 could be transmitted by mosquitoes/housefly
No 631 73.9
Yes 223 26.1
Total myth score 1369
Minimum myth score 0
Maximum myth score 6
Median myth score 2
Practice
Going to crowded places
No 429 50.2
Yes 425 49.8
Stay at home
No 364 42.6
Yes 490 57.4
Reduce consuming outdoor foods
No 306 35.8
Yes 547 64.1
Avoid handshaking
No 208 24.4
Yes 646 75.6
Reduce public transportation
No 386 45.2
Yes 468 54.8
Frequently wash hands
No 164 19.2
Yes 690 80.8
Pay more attention to personal hygiene
No 176 20.6
Yes 678 79.4
Use disinfectants
No 482 56.4
Yes 372 43.6
Use face mask
No 148 17.3
Yes 706 82.7
Maintain safe social distance
No 224 26.2
Yes 630 73.8
Practicing respiratory hygiene
No 150 17.6
Yes 704 82.4
Avoid touching eyes, nose and mouth
No 296 34.7
Yes 558 65.3
Total (sum) of practice score 6904
Minimum practice score 0
Maximum practice score 12
Median practice score 9

Factors associated with risk perception, community myth and practices towards COVID-19 in communities, 2020 (n = 854)

1. Factors associated with risk perception towards COVID-19 pandemic

Seven variables were found to be eligible for multivariable generalized linear model analysis based the results from bivariate output. These are residence, level of education, distance from the health facility, history of chronic illness, knowledge about COVID-19, myth in the community, and status of utilizing COVID-19 preventive practice.

In the final multivariable generalized linear model three factors (variables) were found to be significantly associated with risk perception towards the COVID-19 pandemic. Accordingly residence, distances from health facility and underlining myths were significantly associated with risk perception. Hence being a rural resident increase the likelihood of having high-risk perception by 2.4 (AOR 2.4 with 95%CI 1.67, 3.43) when compared to urban residents, living near health facility also increase the likelihood of having high-risk perception by 1.48 (AOR 1.48 with 95% CI 1.06, 2.06) when compared with those live far from health facility as well as having wrong myth also increase the likelihood of having risk perception by 1.39 (AOR 1.39 with 95% CI 1.2, 1.9) when compared to those without wrong myth. See “Table 3” below.

Table 3. Generalized linear model results of factors associated with risk perception towards COVID-19 pandemic in East Bale and Bale Zone Southeast Ethiopia.
Variables Beta 95 Confidence Interval of beta Hypothesis Test
Lower Upper Wald Chi-Square Df P-value
Residence
Rural 0.873 0.512 1.233 22.486 1 0.000*
Urban 0
Occupation
Gov’t employees 0.102 -0.511 0.716 0.107 1 0.744
NGO employees 0.533 -1.198 2.265 0.364 1 0.546
Private workers 0.086 -0.486 0.658 0.087 1 0.768
Farmers -0.04 -0.585 0.498 0.025 1 0.875
Daily laborers 0
Distance from HF
Near 0.393 0.726 5.356 1 0.021*
Far 0 0.060
History of chronic illness
No -0.412 -0.848 0.024 3.428 1 0.064
Yes 0
Wrong myth
No -0.332 -0.643 -0.022 4.404 1 0.036*
Yes 0
Practice
Poor -0.261 -0.561 0.039 2.899 1 0.089
Good 0
Knowledge
Poor -0.216 -0.536 0.104 1.750 1 .186
Good 0

*Significant factors at P-Value of <0.05, 0 = Reference Category, Df = degree of freedom

2. Factors associated with community myth regarding COVID-19 pandemic

Cluster analysis by using linear mixed model was used to identify factors associated with community myth. Accordingly seven variables were selected for final cluster analysis using a linear mixed model based on bivariate analysis results. These were gender, occupation, residence, distance from the health facility, knowledge regarding COVID-19, level of risk perception, and status of practice regarding utilization of COVID-19 preventive techniques.

In the final multivariable model three variables were found to be significantly associated with community myth. Accordingly being NGO employees, knowledge regarding COVID-19 and status of utilization of COVID-19 preventive techniques were significantly associated with community myth. Being an NGO employee positively related to community myth while poor knowledge regarding COVID-19 and poor utilization of available COVID-19 preventive techniques were negatively associated with the average score of community myth after controlling for the effects of other variables in the model. See “Table 4”.

Table 4. Linear mixed model results of factors associated with community myth towards COVID-19 pandemic in East Bale and Bale Zone Southeast Ethiopia.
Variables Estimate 95% Confidence Interval Df T-value P-value
Lower Upper
Gender
Male -0.053433 -0.210386 0.103520 841 -0.668 0.504
Female 0
Occupation
Gov’t worker -0.248985 -0.577316 0.079346 841 -1.488 0.137
NGO worker 1.466748 0.604466 2.329031 841 3.339 0.001*
Private worker -0.241984 -0.548858 0.064890 841 -1.548 0.122
Farmer -0.266046 -0.555788 0.023697 841 -1.802 0.072
Daily laborer 0
Residence
Rural 0.038332 -0.156203 0.232867 841 0.387 0.699
Urban 0
Distance from HF
Near 0.006825 -0.173489 0.187140 841 0.074 0.941
Far 0
Knowledge
Poor -1.174779 -1.332594 -1.016964 841 -14.611 0.000*
Good 0
Risk perception
Low -0.109217 -0.261076 0.042643 841 -1.412 0.158
High 0
Practice
Poor -.164501 -.326729 -.002272 841 -1.990
Good 0 .047*

*Significant factors at P-Value of <0.05, 0 = Reference Category, HF = health facility, Df = degree of freedom

3. Factors associated with practice towards utilization of COVID-19 preventive measures

Generalized linear model was used to identify factors associated with practice towards utilization of COVID-19 preventive measures. Nine variables were found to be eligible for multivariable generalized linear model analysis by using results from the bivariate analysis.

These are gender, age, education, distance from the health facility, substance use, knowledge about COVID-19, underlining myth, the existing level of risk perception, and monthly income. After running a multivariable generalized linear model four variables were found as factors significantly associated with practice towards utilization of COVID-19 preventive measures. Accordingly having educational status of college and above increases the likelihood of practicing COVID-19 preventive techniques by 4.25 and 2.16 (AOR 4.25 with 95% CI 2.35, 7.69 and 2.16 with 95% CI 1.30, 3.63) when compared with those with no formal education and primary education respectively. Living near a health facility and having good knowledge regarding COVID-19 pandemic increase the likelihood of having good practice in utilizing preventive techniques by 2.14 and 1.88 (AOR 2.14 with 95% CI 1.50, 3.06 and 1.88 with 95% CI 1.34, 2.64) respectively. The final factor that affects the utilization of COVID-19 preventive techniques was the underlining myth individuals hold regarding this pandemic. Hence having a wrong myth towards COVID-19 pandemic increases likelihood of having good practice by 1.42(AOR 1.42 with 95% CI 1.02, 1.99) when compared with those without the wrong myth. See “Table 5” below.

Table 5. Generalized linear model results of factors associated utilization of COVID-19 pandemic preventive measures, East Bale and Bale Zone Southeast Ethiopia.
Variables Beta value Beta 95% Confidence Interval Hypothesis Test
Lower Upper Wald Chi-Square Degree of freedom P-value
Gender
Male -0.324 -0.667 0.018 3.454 1 0.063
Female 0
Residence
Rural 0.181 -0.195 0.557 0.888 1 0.346
Urban 0
Level of education
No formal education -1.447 -2.037 -0.857 23.094 1 0.000*
Primary education -0.773 -1.289 -0.257 8.634 1 0.003*
Secondary education -0.164 -0.731 0.402 0.322 1 0.570
College and above 0
Distance from HF
Near 0.763 0.408 1.119 17.741 1 0.000*
Far 0
Substance use
No 0.321 -0.020 0.662 3.412 1 0.065
Yes 0
Knowledge
Poor -0.634 -0.972 -0.296 13.500 1 0.000*
Good
Risk perception
Low -0.179 -0.489 0.132 1.273 1 0.259
High 0
Wrong myth
No -0.354 -0.688 -0.020 4.322 1 0.038*
Yes 0
Age in years 0.003 -0.010 0.016 0.148 1 0.701

*Significant factors at P-Value of <0.05, 0 = Reference Category, HF = health facility

Discussion

Epidemics and pandemics are unexpected periodic phenomena. They can happen at any time. Peoples face several challenges during such conditions. The effects and impacts of pandemics are multiple. It can affect every aspect of life physically, mentally, and emotionally. Hence in this study, we have investigated risk perception, community myth, and practices towards COVID-19 pandemic and factors associated with them. The risk perception was assessed by giving due attention to emotional and knowledge aspects.

This study found as an around half of or 415 (48.6%) of populations have high-risk perceptions. This finding was the same as the finding from one study conducted in Iran [33] but is higher than the finding from the study conducted in Germany [34] and lower than the finding from the studies conducted in China and Ghana [35, 36]. The disagreement between the current study and studies mentioned could be due to differences in sociodemographic factors like age, residence, educational level and it also might be due to differences in access to information. Also, there is a time difference between when these studies were conducted. The above-mentioned studies were conducted in the early phase of the pandemic. These indicate as level of risk perception in different communities around the world can be different.

This study also found as a rural residence, living near a health facility and having with the wrong myth were significantly and positively associated with risk perception towards the COVID-19 pandemic. This finding conflicts with the studies conducted in Jordan in which urban residence was positively associated with risk perception [37] and it was also not consistent with the other study conducted in China where residence was not significantly associated with risk perception [35, 36]. But this finding was in line with the study conducted in Iran [38].

The reason for the difference could be due to the difference in characteristics of study participants and the speed at which information reach these population based on the status of usage of social media in these different places.

This study also found the prevalence of wrong myths to be 50.1%. This was higher than the finding from a Hospital-based study conducted in Northwest Ethiopia [39]. The reason for disagreement could be the differences in the study setting. Because the current study was community-based while; the study from Northwest Ethiopia was conducted in a health facility which could bring the difference in the finding. The other possible reason could be the time during which these studies were conducted and the difference in the study participants. The study from Northwest Ethiopia was conducted among patients with chronic illness who possibly have regular follow up in the selected Hospital and have a chance to get the right information from health professionals.

This study also identified factors significantly associated with community myths. Accordingly community myth was significantly associated with occupation, knowledge regarding COVID-19, and level of practice regarding utilization of COVID-19 preventive measures. This finding was in line with the finding from the study conducted in South Africa [28] in which knowledge regarding COVID-19 was significantly associated with community myth. But the finding from the current study was not in agreement with the finding from the study conducted in China in which those who have good practice have low myth towards COVID-19 [22]. The reason for the discrepancy could be the difference in sociodemographic characteristics of respondents, the difference in access to information, and the value these communities give for tradition and rumors.

Also, we have found the proportion of people with good practice regarding COVID-19 which is 57.1%. This finding was in line with the other study conducted in Ethiopia [39] where the proportion of poor practice was 47.3%. This was lower than the finding from studies conducted in Nepal and China [22, 24]. The reason for disagreement could be the difference in sociodemographic characteristics of selected study participants as well as it could be due to the difference in receiving correct information and their access to social media. Higher level of education, living near health facility, with good knowledge about the disease and having wrong myth regarding COVID-19 associated with good practice. This finding was in agreement with other studies conducted in China, Pakistan, and Malaysia [21, 22, 39, 40]. But it was different from what was reported in the study conducted in Sudanese [41]. The reason for the difference between these studies and the current study could be due to the difference in the study setting. Because the current study was conducted in the community and the one from Sudan was an online survey which could bring the difference in study participants. This study identified important findings. But it has limitations. Being a crossectional study this study couldn’t identify the direction of association that means whether factors or outcomes come first. It also uses self-report from respondents which could affect the real finding.

Conclusion

This study is an important step towards a better understanding of risk perception, community myth, and practices regarding COVID-19 pandemics and associated factors. Accordingly, relatively high-risk perception, wrong community myth, and poor practice regarding utilization of COVID-19 preventive techniques were reported. Different factors associated with risk perception, community myth, and practices were identified. These findings could be important input for modeling interventional activities in the community.

Supporting information

S1 Questionnaire

(DOCX)

S1 Data

(SAV)

Acknowledgments

Great regards to Madda Walabu University for all support.

Great thanks for study participants.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Bavel J.J.V., et al., Using social and behavioural science to support COVID-19 pandemic response. Nature Human Behaviour, 2020. 4: p. 460–471. doi: 10.1038/s41562-020-0884-z [DOI] [PubMed] [Google Scholar]
  • 2.Naser A.Y.N., et al., Mental health status of the general population, healthcare professionals, and university students during 2019 coronavirus disease outbreak in Jordan: a cross-sectional study. Brain and Behavior, 2020. 10: p. 1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Singhal T., A Review of Coronavirus Disease-2019 (COVID-19). Indian Journal of Pediatrics, 2020. 87(4): p. 281–286. doi: 10.1007/s12098-020-03263-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wolf M.S., et al., Awareness, attitude and action related to COVID-19 among adults with chronic conditions at the onset of the US outbreak. ACP, 2020: p. 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Huynh T.L.D., The COVID-19 risk perception: A survey on socioeconomics and media attention. Economics Bulletin, 2020: p. 758–764. [Google Scholar]
  • 6.European Centre For Diseases Prevention and Control, Outbreak of novel coronavirus disease 2019 (COVID-19): increased transmission globally–fifth update. 2020: Stockholm.
  • 7.Ibuka Y., et al., The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infectiuos diseases, 2010. 10(296): p. 1471–2334. doi: 10.1186/1471-2334-10-296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lennart S., Worry and Risk Perception. Risk Analysis, 1998. 18(1): p. 85–93. doi: 10.1111/j.1539-6924.1998.tb00918.x [DOI] [PubMed] [Google Scholar]
  • 9.Lohiniva A.-L., et al., Understanding coronavirus disease (COVID-19) risk perceptions among the public to enhance risk communication efforts: a practical approach for outbreaks, Finland, February 2020. Euro Surveillance, 2020. 25(13): p. 1560–7917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Casanova M., et al., How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears? Pediatric Blood Cancer., 2020. 67: p. 1–5. doi: 10.1002/pbc.28318 [DOI] [PubMed] [Google Scholar]
  • 11.Mohammad H.T., Roham B., and Ramin S., COVID-19 and Iranian Medical Students; A Survey on Their Related-Knowledge, Preventive Behaviors and Risk Perception. ARCHIVES OF IRANIAN MEDICINE, 2020. 23(4): p. 249–254. doi: 10.34172/aim.2020.06 [DOI] [PubMed] [Google Scholar]
  • 12.Samadipour Ezat, Ghardashi Fatemeh, and Aghaei Nahid, Evaluation of Risk Perception of COVID-19 Disease: A Community-Based Participatory Study. Disaster Medicine and Public Health Preparedness,, 2020: p. 1–8. doi: 10.1017/dmp.2020.311 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McFadden SarahAnn M., et al., Perceptions of the adult US population regarding the novel coronavirus outbreak. Plos One, 2020. 15(4): p. 1–6. doi: 10.1371/journal.pone.0231808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dryhurst S., et al., Risk perceptions of COVID-19 around the world. Journal of risk research, 2020: p. 1–14. [Google Scholar]
  • 15.Mian A. and Khan S., Coronavirus: the spread of misinformation. BMC Medicine 2020. 18(89): p. 1–2. doi: 10.1186/s12916-020-01556-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Khosravi M., Perceived Risk of COVID-19 Pandemic: The Role of Public Worry and Trust. Electronic Journal of General Medicine,, 2020. 17(4): p. 2516–3507. [Google Scholar]
  • 17.Wise T., et al., Changes in risk perception and self-reported protective behaviour during the first week of the COVID-19 pandemic in the United States. Royal Societ Publishing, 2020. 7: p. 1–13. doi: 10.1098/rsos.200742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Huynh T.L.D., The COVID-19 risk perception: A survey on socioeconomics and media attention. Economics Bulletin, 2020. 40(1): p. 758–764. [Google Scholar]
  • 19.Ibuka Y., et al., The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infectiuos diseases 2020: p. 1471–2334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Naser A.Y., et al., Mental health status of the general population, healthcare professionals, and university students during 2019 coronavirus disease outbreak in Jordan: a cross-sectional study. . 2020: p. 1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jelnov, P., Confronting COVID-19 Myths: Morbidity and Mortality, in GLO Discussion Paper, No. 516,, 516, Editor. 2020. p. 1–7.
  • 22.Swapnajeet S., Susanta Kumar Padhy J.I., and Aseem Mehra S.G., Demystifying the myths about COVID-19 infection and its societal importance. Asian Journal of Psychiatry 2020. 54: p. 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dryhurst Sarah, et al., Risk perceptions of COVID-19 around the world. Journal of Risk Research, 2020. 23(7–8): p. 994–1006. [Google Scholar]
  • 24.Sarla G.S., COVID 19: Myths and Facts. MAT journal, 2020. 2(2): p. 5–8. [Google Scholar]
  • 25.FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA, Demographic and Health Survey. 2016: Addis Ababa, Ethiopia.
  • 26.Casanova M., et al., How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears?.. Pediatr Blood Cancer, 2020: p. 1–5. doi: 10.1002/pbc.28318 [DOI] [PubMed] [Google Scholar]
  • 27.Dryhurst S., et al., Risk perceptions of COVID-19 around the world. Journal of risk research, 2020: p. 1–14. [Google Scholar]
  • 28.Schmidt Tenielle, et al., Myths, misconceptions, othering and stigmatizing responses to Covid-19 in South Africa: A rapid qualitative assessment. Plos One, 2020. 15(12). doi: 10.1371/journal.pone.0244420 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ferdous Most. Zannatul, et al., Knowledge, attitude, and practice regarding COVID-19 outbreak in Bangladesh: An onlinebased cross-sectional study. Plos One, 2020. 15(10). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.WHO, Mental health and psychosocial considerations during the COVID-19 outbreak. 2020: Geneva. [Google Scholar]
  • 31.Wolf M.S., et al., Awareness, attitude and action related to COVID-19 among adults with chronic conditions at the onset of the US outbreak. Annals of Internal Medicine, 2020. 173(2): p. 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wu Y.-C., Chen C.-S., and Chan Y.-J., The outbreak of COVID-19: An overview. J Chin Med Assoc, 2020. 83: p. 217–220. doi: 10.1097/JCMA.0000000000000270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Honarvar Behnam, et al., Knowledge, attitudes, risk perceptions, and practices of adults toward COVID-19: a population and field-based study from Iran International Journal of Public Health, 2020. 65: p. 731–739. doi: 10.1007/s00038-020-01406-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gerhold L., COVID-19: Risk perception and Coping strategies. Results from a survey in Germany. AG, 2020: p. 1–11. [Google Scholar]
  • 35.Serwaa Dorcas, et al., Knowledge, risk perception and preparedness towards coronavirus disease-2019 (COVID-19) outbreak among Ghanaians: a quick online cross-sectional survey. Pan African Medical Journal,, 2020. 35(44): p. 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.He Shan, et al., Analysis of Risk Perceptions and Related Factors Concerning COVID‑19 Epidemic in Chongqing, China. Journal of Community Health 2021. 46: p. 278–285. doi: 10.1007/s10900-020-00870-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Karasneh Reema, et al., Media’s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. . Research in Social and Administrative Pharmacy,, 2020. 17: p. 1897–1902. doi: 10.1016/j.sapharm.2020.04.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Samadipour Ezat and Ghardash Fatemeh, Factors Influencing Iranians’ Risk Perception of Covid-19. Journal of Military Medicine, 2020. 22(2): p. 122–129. [Google Scholar]
  • 39.Akalu Yonas, Ayelign Birhanu, and Molla Meseret Derbew, Knowledge, Attitude and Practice Towards COVID-19 Among Chronic Disease Patients at Addis Zemen Hospital, Northwest Ethiopia. Dove Press Journal infection and Drug Resistance, 2020. 13: p. 1949–1960. doi: 10.2147/IDR.S258736 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Amgain Kapil, et al., Myths versus Truths regarding the Novel Coronavirus Disease (COVID-2019) Outbreak. Journal of Karnali Academy of Health Sciences, 2020. 3(7): p. 1–6. [Google Scholar]
  • 41.Mohamed Amal Abdelrahim Osman, et al., Knowledge, attitude and practice of the Sudanese people towards COVID-19: an online survey. BMC Public Health, 2021. 21(274): p. 1–7. doi: 10.1186/s12889-021-10319-5 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jong In Kim

25 Jan 2022

PONE-D-21-40289Risk perception, community myth, and practices towards COVID-19 pandemic in Southeast Ethiopia: Community based crossectional studyPLOS ONE

Dear Dr. Aliyi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jong In Kim

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. 

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

● The name of the colleague or the details of the professional service that edited your manuscript

● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

● A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

4. Thank you for stating the following financial disclosure: 

" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Funding Section of your manuscript: 

"This study was funded by Madda Walabu University. The funders had no role in study design, data collection, and analysis, or preparation of the manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

7. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

Additional Editor Comments:

This study aims to assess risk perception, community myths, and preventive practice towards COVID-19 in Ethiopia, 2020.

A community-based cross-sectional study was conducted among 854 participants selected using a multistage sampling technique.

From 854 respondents included in this study, 428 (50.1%) have a wrong tale about COVID-19, and 366 (42.9%) have poor practice, respectively. Thus, the study lays out high-risk perceptions, false community myths, and relatively low utilization of available methods towards COVID-19 and their associated factors.

1. On time, I evaluate it is good to investigate the awareness level of the country, in informing the international community that has a wrong tale about COVID-19.

2. Please supplement the discussion further to reinforce the direction of improvement for health promotion against problems of COVID-19 in Ethiopia.

See also the following paper:

In Kim, J., Kim, G. & Choi, Y. Effects of air pollution on children from a socioecological perspective. BMC Pediatr 19, 442 (2019). https://doi.org/10.1186/s12887-019-1815-x

Kim, J.I., Kim, G. Effects on inequality in life expectancy from a social ecology perspective. BMC Public Health 18, 243 (2018). https://doi.org/10.1186/s12889-018-5134-1

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-21-40289.docx

PLoS One. 2022 Oct 3;17(10):e0275331. doi: 10.1371/journal.pone.0275331.r002

Author response to Decision Letter 0


14 Mar 2022

RESPONSE TO REVIEWERS

Thank you for reading and commenting our manuscript. We have made changes as per given comments. The responses were provided in the following table.

Thank you again

COMMENTS RESPONSES

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: Thank you for your comment. We have revised our manuscript as per the requirements. Thank you again

2. Please review your refer ence list to ensure that it is complete and correct.

Response: Thank you for your comment. We have revised our references but we couldn’t find problem. Thank you again

3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Response: Thank you for your comments. We have thoroughly edit the manuscript to make it clear and informative. We have highlighted bold where changes were made. Thank you again.

4. Thank you for stating the following financial disclosure:

" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response: Thank you for your comments. We have made changes accordingly. Thank you againn

5. Thank you for stating the following in the Funding Section of your manuscript:

"This study was funded by Madda Walabu University. The funders had no role in study design, data collection, and analysis, or preparation of the manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response: Thank you for your comments. We have incorporated this comments and make modification accordingly. We have have removed the funding information from acknowledgment section

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found

Response: Thank you for your comments. We have submitted minimal data as supporting information along with this submission

Thank you again

7. Your ethics statement should only appear in the Methods section of your manuscript

Response: Thank you for your comment. We made it accordingly and write ethics statement on only methods section. Thank you again.

Attachment

Submitted filename: RESPONSE TO REVIEWERS.docx

Decision Letter 1

Jong In Kim

23 Mar 2022

PONE-D-21-40289R1Risk perception, community myth, and practices towards COVID-19 pandemic in Southeast Ethiopia: Community based crossectional studyPLOS ONE

Dear Dr. Aliyi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jong In Kim

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Please supplement the discussion further to reinforce the direction of improvement for health promotion against problems of COVID-19 in Ethiopia.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Oct 3;17(10):e0275331. doi: 10.1371/journal.pone.0275331.r004

Author response to Decision Letter 1


30 Mar 2022

RESPONSE TO REVIEWERS

Thank you for reading and commenting our manuscript. We have made changes as per given comments. The responses were provided in the following table.

Thank you again

COMMENTS RESPONSES

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you for your comment. We have revised our manuscript as per the requirements. Thank you again

2. Please review your refer ence list to ensure that it is complete and correct.

Thank you for your comment. We have revised our references but we couldn’t find problem. Thank you again

3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Thank you for your comments. We have thoroughly edits the manuscript to make it clear and informative. We have highlighted bold where changes were made. Thank you again.

4. Thank you for stating the following financial disclosure:

" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Thank you for your comments. We have made changes accordingly. Thank you again

5. Thank you for stating the following in the Funding Section of your manuscript:

"This study was funded by Madda Walabu University. The funders had no role in study design, data collection, and analysis, or preparation of the manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Thank you for your comments. We have incorporated these comments and make modification accordingly. We have removed the funding information from acknowledgment section

6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found Thank you for your comments. We have submitted minimal data as supporting information along with this submission

Thank you again

7. Your ethics statement should only appear in the Methods section of your manuscript Thank you for your comment. We made it accordingly and write ethics statement on only methods section. Thank you again.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Thank you for your comment. We have updated all references for their completeness. And we have remove references used mistakenly before their publication (preprint).

Thank you again

Attachment

Submitted filename: Response to Reviewer.docx

Decision Letter 2

Soham Bandyopadhyay

15 Aug 2022

PONE-D-21-40289R2Risk perception, community myth, and practices towards COVID-19 pandemic in Southeast Ethiopia: Community based crossectional studyPLOS ONE

Dear Dr. Aliyi

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Soham Bandyopadhyay

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The manuscript adds useful information about the risk perception, community myth, and practices towards COVID-19 pandemic in the Africa setting. I have the following specific comments for the authors' consideration:

a. The introduction section of the manuscript needs revision with emphasis on style of English. Some of the sentences are not written in standard English.

b. Line 51 - replace “.” and “And” with ","

c. Line 67 - replace "can transmit" with “can also be transmitted”

d. Line 200 - remove “shows”, include "N" and remove "female" from table 1

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohammedaman Mama Hussen

Reviewer #2: Yes: Ms. Catherine Okoi

**********

PLoS One. 2022 Oct 3;17(10):e0275331. doi: 10.1371/journal.pone.0275331.r006

Author response to Decision Letter 2


18 Aug 2022

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Thank for reviewing our paper by giving your precious time. Thank you again

________________________________________

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Thank for reviewing our paper by giving your precious time. Thank you again

________________________________________

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

Thank for reviewing our paper by giving your precious time. Thank you again

________________________________________

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Thank for reviewing our paper by giving your precious time. Thank you again

________________________________________

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The manuscript adds useful information about the risk perception, community myth, and practices towards COVID-19 pandemic in the Africa setting. I have the following specific comments for the authors' consideration:

a. The introduction section of the manuscript needs revision with emphasis on style of English. Some of the sentences are not written in standard English.

b. Line 51 - replace “.” and “And” with ","

c. Line 67 - replace "can transmit" with “can also be transmitted”

d. Line 200 - remove “shows”, include "N" and remove "female" from table 1

________________________________________

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Thank for reviewing our paper by giving your precious time. We have incorporated the comment raised in the tack changes manuscript. Thank you again

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohammedaman Mama Hussen

Reviewer #2: Yes: Ms. Catherine Okoi

Thank for reviewing our paper by giving your precious time. Thank you again

Attachment

Submitted filename: response to reviewer.docx

Decision Letter 3

Soham Bandyopadhyay

14 Sep 2022

Risk perception, community myth, and practices towards COVID-19 pandemic in Southeast Ethiopia: Community based crossectional study

PONE-D-21-40289R3

Dear Dr.  Aliyi

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Soham Bandyopadhyay

Academic Editor

PLOS ONE

Acceptance letter

Soham Bandyopadhyay

21 Sep 2022

PONE-D-21-40289R3

Risk perception, community myth, and practices towards COVID-19 pandemic in Southeast Ethiopia: Community based crossectional study

Dear Dr. Aliyi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Soham Bandyopadhyay

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Questionnaire

    (DOCX)

    S1 Data

    (SAV)

    Attachment

    Submitted filename: PONE-D-21-40289.docx

    Attachment

    Submitted filename: RESPONSE TO REVIEWERS.docx

    Attachment

    Submitted filename: Response to Reviewer.docx

    Attachment

    Submitted filename: response to reviewer.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES